title: Sequence requirements for incorporation of human immunodeficiency virus gag-beta-galactosidase fusion proteins into virus-like particles.
abstract: The incorporation of human immunodeficiency virus type 1 (HIV-1) Gag-beta-galactosidase (Gag-beta-gal; GBG) fusion proteins into HIV virus-like particles in the presence of HIV Gag proteins was studied. HIV Gag-beta-gal fusion constructs were cotransfected individually into COS7 cells with or without an HIV Gag protein expression plasmid. Release of HIV GBG fusion proteins from the cells were measured by assay of the medium versus intracellular beta-gal activities. Analysis indicates that fusion proteins (constructs HIVGBG, GBG 1919 and 1877) retaining the C-terminal portion of the CA and the adjacent NC domains were efficiently assembled into virus-like particles. Fusion proteins with deleted sequences covering the N-terminal portions of the gag sequences (GBG 831, 1147, 1419, 1447, 1511, 1552, 1600, 1630, 1684, 1715, and 1752) were impaired in entry into virus-like particles. The presence of CA major homology region (MHR) in the fusion proteins had no significant effects on inducing fusion protein incorporation when the C-terminal CA sequences in the fusion proteins were truncated (GBG 1841 and 1801). Subcellular fractionation studies indicated that most fusion proteins including the nonmyristylated one were enriched in the crude membrane fraction. Exceptions to this rule were fusion proteins with intact MHR but truncated C-terminal CA sequences, which possessed low levels of membrane association. However, assembly of fusion proteins into HIV Gag particles did not correlate with their subcellular fractionation or immunofluorescence localization patterns. Overall, the studies suggest that the very C-terminal CA and adjacent NC sequences are the primary determinants for incorporation of HIV Gag-beta-gal fusion proteins into virus particles.
authors.affiliation: Institute of Clinical Medicine, National Yang-Ming University School of Medicine, and Department of Medical Research and Education, Veterans General Hospital-Taipei, Taiwan, Republic of China. ctwang@vghtpe.gov.tw
authors.forename: C T
authors.initials: CT
authors.lastname: Wang
authors.forename: H Y
authors.initials: HY
authors.lastname: Lai
authors.forename: C C
authors.initials: CC
authors.lastname: Yang
mesh_terms: D000818:Animals; D015153:Blotting, Western; D019556:COS Cells; D015870:Gene Expression; D015683:Gene Products, gag / Q000235:genetics*; D006678:HIV / Q000235:genetics*; D006801:Humans; D008856:Microscopy, Fluorescence; D011993:Recombinant Fusion Proteins / Q000235:genetics* / Q000378:metabolism; D014162:Transfection; D014760:Viral Fusion Proteins / Q000235:genetics* / Q000378:metabolism
chemical_list: D015683:Gene Products, gag; D011993:Recombinant Fusion Proteins; D014760:Viral Fusion Proteins